Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Deep Vein Thrombosis
DVT risk may be higher in users of combined HRT
July 14th, 2005
Postmenopausal women who use combined estrogen-progestin hormone replacement therapy (HRT) may be at higher risk of developing deep vein thrombosis than those using estrogen-only HRT. "Although hormone replacement therapy HRT is associated with an increased risk of deep vein thrombosis (DVT), it is not clear if the risk differs in users of combined estrogen-progestin HRT and estrogen-only HRT," wrote J.D. Douketis and colleagues, St. Joseph's Hospital, Hamilton, Ontario. "We prospectively studied postmenopausal women with suspected DVT in whom HRT use status was ascertained and who subsequently had objective diagnostic testing to confirm or exclude...
Source: Women's Health Weekly (2005-07-14)
|
